IRIS
RAIMONDO, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.954
NA - Nord America 10.800
AS - Asia 6.193
SA - Sud America 2.144
AF - Africa 205
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 5
Totale 32.318
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.599
RU - Federazione Russa 6.595
SG - Singapore 2.487
CN - Cina 1.908
BR - Brasile 1.859
IE - Irlanda 1.599
SE - Svezia 1.418
IT - Italia 825
HK - Hong Kong 674
DE - Germania 581
UA - Ucraina 406
FR - Francia 373
VN - Vietnam 353
FI - Finlandia 302
PL - Polonia 268
GB - Regno Unito 249
IN - India 178
AR - Argentina 93
CA - Canada 90
BE - Belgio 76
BD - Bangladesh 72
TR - Turchia 67
MX - Messico 65
AT - Austria 59
ZA - Sudafrica 59
ID - Indonesia 57
IQ - Iraq 56
EC - Ecuador 45
NL - Olanda 43
JP - Giappone 42
PK - Pakistan 41
CO - Colombia 39
ES - Italia 39
MA - Marocco 38
UZ - Uzbekistan 37
CZ - Repubblica Ceca 31
VE - Venezuela 27
CI - Costa d'Avorio 24
PY - Paraguay 23
CL - Cile 19
AE - Emirati Arabi Uniti 18
KE - Kenya 18
AZ - Azerbaigian 17
JO - Giordania 17
LT - Lituania 17
PH - Filippine 17
SA - Arabia Saudita 16
BO - Bolivia 15
TN - Tunisia 15
DZ - Algeria 14
IL - Israele 14
LB - Libano 14
NP - Nepal 14
IR - Iran 13
KZ - Kazakistan 13
PE - Perù 13
KG - Kirghizistan 12
NZ - Nuova Zelanda 11
UY - Uruguay 11
GR - Grecia 10
JM - Giamaica 10
OM - Oman 9
EG - Egitto 8
EE - Estonia 7
MY - Malesia 7
PT - Portogallo 7
AU - Australia 6
BG - Bulgaria 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
HN - Honduras 6
LV - Lettonia 6
BY - Bielorussia 5
BZ - Belize 5
KW - Kuwait 5
NO - Norvegia 5
PS - Palestinian Territory 5
SN - Senegal 5
AM - Armenia 4
AO - Angola 4
GT - Guatemala 4
KR - Corea 4
PA - Panama 4
RO - Romania 4
RS - Serbia 4
SY - Repubblica araba siriana 4
AL - Albania 3
BN - Brunei Darussalam 3
CR - Costa Rica 3
DK - Danimarca 3
EU - Europa 3
LY - Libia 3
MD - Moldavia 3
QA - Qatar 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
GE - Georgia 2
HU - Ungheria 2
LK - Sri Lanka 2
Totale 32.288
Salva come PNG Salva come JPEG
Città #
Ashburn 2.082
Moscow 2.022
Dublin 1.599
Singapore 1.443
Dallas 1.324
Chandler 1.074
Nyköping 837
Jacksonville 836
Beijing 675
Hong Kong 673
Messina 414
San Jose 374
The Dalles 338
Ann Arbor 253
Los Angeles 253
Warsaw 249
Princeton 246
Medford 223
Lauterbourg 216
Cambridge 188
Des Moines 179
Munich 167
São Paulo 157
Dearborn 145
Ho Chi Minh City 125
New York 123
Boardman 118
Buffalo 92
Woodbridge 85
Wilmington 81
Houston 79
Jinan 74
Brussels 72
Tianjin 71
Frankfurt am Main 69
Hanoi 68
Redondo Beach 66
Orem 63
Helsinki 62
Guangzhou 59
San Mateo 58
Rio de Janeiro 57
Nanjing 54
Shenyang 54
Belo Horizonte 53
Brasília 53
Turku 50
Council Bluffs 45
Chennai 42
Seattle 42
Tokyo 42
Rome 41
Nuremberg 40
Santa Clara 40
Hebei 38
Vienna 37
Falls Church 36
Haikou 35
Pune 35
Brooklyn 33
Shenzhen 32
Zhengzhou 32
Shanghai 31
Tashkent 31
Jakarta 30
Stockholm 30
Catania 28
Phoenix 28
Atlanta 27
Chicago 27
Hyderabad 27
Porto Alegre 27
Baghdad 26
Curitiba 26
Montreal 26
Amsterdam 25
Bremen 25
Abidjan 24
Johannesburg 24
San Francisco 24
Boston 23
Lancaster 23
Brno 22
Dong Ket 22
Guarulhos 21
Ottawa 21
Campinas 20
London 20
Nanchang 20
Ningbo 20
Hangzhou 19
Manchester 19
Mumbai 19
Poplar 19
Denver 18
Düsseldorf 18
Haiphong 18
Mexico City 18
Ankara 16
Baku 16
Totale 19.101
Salva come PNG Salva come JPEG
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 376
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 266
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 264
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 264
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 260
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 248
Atrial fibrillation in patients with cirrhosis 244
Hepatitis B virus (HBV) markers and HBV-DNA in serum and liver tissue of patients with acute exacerbation of chronic type B hepatitis 224
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 223
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 217
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 214
Risk Factors Associated with NASH in Obese Patients Undergoing Bariatric Surgery NASH and bariatric surgery 213
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 209
HBE ANTIBODY UNRELATED TO E-MINUS HEPATITIS-B VIRUS VARIANT INFECTION IN PATIENTS WITH CHRONIC TYPE-D HEPATITIS 208
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 207
A combination of different diagnostic tools allows identification of inactive hepatitis B virus carriers at a single time point evaluation 207
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 206
Does the margin width influence recurrence rate in liver surgery for hepatocellular carcinoma smaller than 5 cm? 205
Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease? 202
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 202
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 200
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 200
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta virus superinfection. 199
A GENETIC-POLYMORPHISM OF THE APOLIPOPROTEIN AI-CIII GENE- CLUSTER IS ASSOCIATED WITH CORONARY HEART-DISEASE IN NON- INSULIN-DEPENDENT DIABETES-MELLITUS 198
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 197
Erectile dysfunction in compensated liver cirrhosis 197
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. 195
An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers 191
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 190
Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy 190
Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease. 190
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 188
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 187
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 187
Control of cccDNA function in hepatitis B virus infection. 186
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 184
ALFA-INTERFERON TREATMENT INDUCES INSULIN AUTOANTIBODIES IN PATIENTS WITH CHRONIC VIRAL-HEPATITIS 183
Exacerbation of chronic liver disease due to hepatitis B surface antigen after delta infection. 182
Cirrhosis related to wild-type HBV infection in siblings with A3 - B35 - Cw4 HLA class I phenotype. 182
Fibroscan: a new non-invasive method for evaluation of liver dysfunction in Turner syndrome 180
Outcome of cutaneous psoriasis in hepatitis C virus-infected patients treated with Direct-Acting Antiviral therapy 180
[A glance into the past ... Southern and northern blot: really superseded?] 179
Mitochondrial DNA is a target of HBV integration 178
HEPATITIS-B VIRUS VARIANT, WITH A DELETION IN THE PRES2 AND 2 TRANSLATIONAL STOP CODONS IN THE PRECORE REGIONS, IN A PATIENT WITH HEPATOCELLULAR-CARCINOMA 176
Is there a downgrading in the alert about the hepatitis B virus infection in Italy? 174
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 171
A 2010 update on occult hepatitis B infection. 170
Analysis of HBV integration in mitochondrial DNA of HepAD38 cells by the high-throughput HBV integration sequencing and RNASeq approaches 168
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 168
Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones 166
Evaluation of liver enzyme levels and identification of asymptomatic liver disease patients in primary care 166
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 166
Clinical virology of hepatitis B virus infection 165
Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. 165
Human hepatitis B virus negatively impacts the protective immune cross-talk between natural killer and dendritic cells 165
Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection 165
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis? 164
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 164
A NEW HEPATITIS-B VIRUS VARIANT IN A CHRONIC CARRIER WITH MULTIPLE EPISODES OF VIRAL REACTIVATION AND ACUTE HEPATITIS 163
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 161
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 160
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 159
Low prevalence of hepatitis B and hepatitis C virus serum markers in a cohort of pregnant women from Southern Italy 158
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia 157
Flavocoxid exerts a potent antiviral effect against hepatitis B virus. 157
Antibodies to hepatitis A virus in Italian patients with chronic liver disease 155
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta superinfection. 155
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 155
Correlates of total homocysteine plasma concentration in type 2 diabetes 154
Hepatitis B e antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection. 154
Ipertransaminasemia persistente in una coorte di pazienti diabetici di tipo 2: prevalenza e correlazioni cliniche 154
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 154
Disease progression and liver cancer in the ferroportin disease. 154
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 153
BILE DUCTOPENIA FOLLOWING THERAPY WITH SULPIRIDE 150
Effectiveness of add-on Pegylated interferon alfa-2a therapy in a Lamivudine-treated patient with chronic hepatitis B 150
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 150
Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts. 149
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 (IL8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY 149
Effetto della menopausa sui livelli di omocisteina e sul polimorfismo C677T della metilenetetraidrofolato reduttasi nelle donne con diabete mellito di tipo 2 149
Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8Production which in Turn Inhibits Interferon-alfa Antiviral Activity 149
Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma 147
IPERTRANSAMINASEMIAQ PERSISTENTE IN UNA COORTE DI PAZIENTI DIABETICI DI TIPO 2: PREVALENZA E CORRELAZIONI CLINICHE. 147
Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. 147
HISTOLOGICAL BEHAVIOR OF CHRONIC HEPATITIS IN PATIENTS TREATED WITH ALPHA-INTERFERON 146
High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy. 146
ABNORMAL ALANINE AMINOTRANSFERASE ACTIVITY REFLECTS EXPOSURE TO HEPATITIS-C VIRUS IN HEMODIALYSIS-PATIENTS 145
Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis. 144
Seroprevalence of hepatitis B virus and hepatitis C virus infections in elderly residents in nursing homes in Southern Italy 144
Obesity and liver cancer 144
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 143
Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre study 142
Pattern of macrovascular invasion in hepatocellular carcinoma 141
CHRONIC HEPATITIS IN PATIENTS WITH ACTIVE HEPATITIS-B VIRUS AND HEPATITIS-C VIRUS COMBINED INFECTIONS - A HISTOLOGICAL STUDY 141
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 N(IL-8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INERFERON ALFA ANTIVIRAL ACITIVITY 141
The changing scenario of hepatocellular carcinoma in Italy: an update 141
Molecular analyses of TT virus in paired and tissue samples from 150 patients with either hepatic or non-hepatic disease 139
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 139
The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. 138
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents. 138
Totale 17.777
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.624
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.624
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021362 0 0 0 0 0 0 0 0 0 180 108 74
2021/20221.639 20 153 48 58 95 33 126 59 29 281 216 521
2022/20234.528 334 464 224 320 309 451 81 246 1.896 31 134 38
2023/20241.189 81 180 54 104 100 197 19 248 6 56 34 110
2024/20255.245 78 75 139 347 274 221 209 1.054 1.232 309 460 847
2025/202615.595 718 1.237 1.211 1.097 1.285 3.393 2.031 1.964 2.047 612 0 0
Totale 32.769